Skip to main content
Log in

Impact of persistent endothelial dysfunction in an infarct-related coronary artery on future major adverse cardiovascular event occurrence in STEMI survivors

  • Original Article
  • Published:
Heart and Vessels Aims and scope Submit manuscript

Abstract

Although coronary endothelial vasomotor dysfunction predicts future coronary events, few human studies have shown the relationship between persistent endothelial vasomotor dysfunction and major adverse cardiovascular events (MACE) using serial assessments in the same coronary artery. This study examined whether persistent endothelial vasomotor dysfunction is related to MACE occurrence in the infarct-related coronary artery (IRA) of ST-segment elevation myocardial infarction (STEMI) survivors using serial assessments of the coronary vasomotor response to acetylcholine (ACh). This study included 169 consecutive patients with a first acute STEMI due to left anterior descending coronary artery (LAD) occlusion and successful reperfusion therapy with percutaneous coronary intervention. Vasomotor response to ACh in the LAD was measured within 2 weeks of acute myocardial infarction (AMI) (first test) and repeated 6 months (second test) after AMI under optimal anti-atherosclerotic therapy. MACE was defined as the composite of all-cause death, non-fatal MI, angina recurrence requiring percutaneous intervention or surgical bypass, and hospitalization for heart failure. We followed up 126 patients for a period of ≤ 60 months until MACE occurrence after second test. Nineteen MACEs occurred during the follow-up. The log-rank test, Kaplan–Meier curves and univariate Cox proportional hazards regression analysis showed that MACE occurrence was significantly associated with the persistent impairment of epicardial coronary artery dilation and coronary blood flow increases in response to ACh (log-rank test, p < 0.001 and p < 0.001, respectively) (Hazard ratio, p = 0.001 and p = 0.002, respectively). Persistent impairment of endothelial vasomotor function in the infarct-related conduit arterial segment and resistance arteriole were the significant predictor of future MACE occurrence in STEMI survivors.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

Data interpretation

All authors take responsibility for all aspects of the reliability and freedom from bias of the data presented and their discussed interpretation.

References

  1. Ku D (1982) Coronary vascular reactivity after acute myocardial ischemia. Science 218:576–578

    Article  CAS  Google Scholar 

  2. VanBenthuysen KM, McMurtry IF, Horwitz LD (1987) Reperfusion after acute coronary occlusion in dogs impairs endothelium-dependent relaxation to acetylcholine and augments contractile reactivity in vitro. J Clin Invest 79:265–274

    Article  CAS  Google Scholar 

  3. Obata JE, Kitta Y, Takano H, Kodama Y, Nakamura T, Mende A, Kawabata K, Saitoh Y, Fujioka D, Kobayashi T, Yano T, Kugiyama K (2007) Sirolimus-eluting stent implantation aggravates endothelial vasomotor dysfunction in the infarct-related coronary artery in patients with acute myocardial infarction. J Am Coll Cardiol 50:1305–1309

    Article  CAS  Google Scholar 

  4. Obata JE, Nakamura T, Kitta Y, Kodama Y, Sano K, Kawabata K, Saitoh Y, Fujioka D, Kobayashi T, Yano T, Watanabe Y, Watanabe K, Kugiyama K (2009) Treatment of acute myocardial infarction with sirolimus-eluting stents results in chronic endothelial dysfunction in the infarct-related coronary artery. Circ Cardiovasc Interv 2:384–391

    Article  Google Scholar 

  5. Lefer AM, Tsao PS, Lefer DJ, Ma XL (1991) Role of endothelial dysfunction in the pathogenesis of reperfusion injury after myocardial ischemia. FASEB J 5:2029–2034

    Article  CAS  Google Scholar 

  6. Janssens S, Pokreisz P, Schoonjans L, Pellens M, Vermeersch P, Tjwa M, Jans P, Scherrer-Crosbie M, Picard MH, Szelid Z, Gillijns H, Van de Werf F, Collen D, Bloch KD (2004) Cardiomyocyte-specific overexpression of nitric oxide synthase 3 improves left ventricular performance and reduces compensatory hypertrophy after myocardial infarction. Circ Res 94:1256–1262

    Article  CAS  Google Scholar 

  7. Scherrer-Crosbie M, Ullrich R, Bloch KD, Nakajima H, Nasseri B, Aretz HT, Lindsey ML, Vançon A-C, Huang PL, Lee RT, Zapol WM, Picard MH (2001) Endothelial nitric oxide synthase limits left ventricular remodeling after myocardial infarction in mice. Circulation 104:1286–1291

    Article  CAS  Google Scholar 

  8. Abdel Hamid M, Bakhoum SW, Sharaf Y, Sabry D, El-Gengehe AT, Abdel-Latif A (2016) Circulating endothelial cells and endothelial function predict major adverse cardiac events and early adverse left ventricular remodeling in patients with st-segment elevation myocardial infarction. J Interv Cardiol 29:89–98

    Article  Google Scholar 

  9. Yeboah J, Folsom AR, Burke GL, Johnson C, Polak JF, Post W, Lima JA, Crouse JR, Herrington DM (2009) Predictive value of brachial flow-mediated dilation for incident cardiovascular events in a population-based study: the multi-ethnic study of atherosclerosis. Circulation 120:502–509

    Article  Google Scholar 

  10. Suwaidi JA, Hamasaki S, Higano ST, Nishimura RA, Holmes DR, Lerman A (2000) Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction. Circulation 101:948–954

    Article  CAS  Google Scholar 

  11. Schachinger V, Britten MB, Zeiher AM (2000) Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease. Circulation 101:1899–1906

    Article  CAS  Google Scholar 

  12. Halcox JPJ, Schenke WH, Zalos G, Mincemoyer R, Prasad A, Waclawiw MA, Nour KRA, Quyyumi AA (2002) Prognostic value of coronary vascular endothelial dysfunction. Circulation 106:653–658

    Article  Google Scholar 

  13. Heitzer T, Schlinzig T, Krohn K, Meinertz T, Münzel T (2001) Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease. Circulation 104:2673–2678

    Article  CAS  Google Scholar 

  14. Kitta Y, Obata JE, Nakamura T, Hirano M, Kodama Y, Fujioka D, Saito Y, Kawabata K, Sano K, Kobayashi T, Yano T, Nakamura K, Kugiyama K (2009) Persistent impairment of endothelial vasomotor function has a negative impact on outcome in patients with coronary artery disease. J Am Coll Cardiol 53:323–330

    Article  Google Scholar 

  15. Horikoshi T, Obata JE, Nakamura T, Fujioka D, Watanabe Y, Nakamura K, Watanabe K, Saito Y, Kugiyama K (2019) Persistent dysfunction of coronary endothelial vasomotor responses is related to atheroma plaque progression in the infarct-related coronary artery of ami survivors. J Atheroscler Thromb 26:1062–1074

    Article  CAS  Google Scholar 

  16. Obata JE, Horikoshi T, Nakamura T, Kugiyama K (2019) Sustained endothelial dysfunction in the infarct-related coronary artery is associated with left ventricular adverse remodeling in survivors of st-segment elevation myocardial infarction. J Cardiol 75:261–269

    Article  Google Scholar 

  17. Meredith IT, Anderson TJ, Uehata A, Yeung AC, Selwyn AP, Ganz P (1993) Role of endothelium in ischemic coronary syndromes. Am J Cardiol 72:27C-31C

    Article  CAS  Google Scholar 

  18. Vanhoutte PM (2009) Endothelial dysfunction. Circ J 73:595–601

    Article  CAS  Google Scholar 

  19. Antman EM, Anbe DT, Armstrong PW, Bates ER, Green LA, Hand M, Hochman JS, Krumholz HM, Kushner FG, Lamas GA, Mullany CJ, Ornato JP, Pearle DL, Sloan MA, Smith SC Jr, Alpert JS, Anderson JL, Faxon DP, Fuster V, Gibbons RJ, Gregoratos G, Halperin JL, Hiratzka LF, Hunt SA, Jacobs AK, American College of Cardiology, American Heart Association Task Force on Practice G (2004) Acc/aha guidelines for the management of patients with st-elevation myocardial infarction–executive summary: a report of the american college of cardiology/american heart association task force on practice guidelines (writing committee to revise the 1999 guidelines for the management of patients with acute myocardial infarction). Circulation 110:588–636

    Article  Google Scholar 

  20. Expert Panel on Detection Evaluation, and Treatment of High Blood Cholesterol in Adults (2001) Executive summary of the third report of the national cholesterol education program (ncep) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel iii). JAMA 285:2486–2497

    Article  Google Scholar 

  21. Kugiyama K, Doi H, Motoyama T, Soejima H, Misumi K, Kawano H, Nakagawa O, Yoshimura M, Ogawa H, Matsumura T, Sugiyama S, Nakano T, Nakajima K, Yasue H (1998) Association of remnant lipoprotein levels with impairment of endothelium-dependent vasomotor function in human coronary arteries. Circulation 97:2519–2526

    Article  CAS  Google Scholar 

  22. Gould KL, Lipscomb K (1974) Effects of coronary stenoses on coronary flow reserve and resistance. Am J Cardiol 34:48–55

    Article  CAS  Google Scholar 

  23. Quyyumi AA, Dakak N, Andrews NP, Husain S, Arora S, Gilligan DM, Panza JA, Cannon RO 3rd (1995) Nitric oxide activity in the human coronary circulation. Impact of risk factors for coronary atherosclerosis. J Clin Invest 95:1747–1755

    Article  CAS  Google Scholar 

  24. Bonetti PO, Lerman LO, Lerman A (2003) Endothelial dysfunction. Arterioscler Thromb Vasc Biol 23:168–175

    Article  CAS  Google Scholar 

  25. Zeiher AM, Drexler H, Saurbier B, Just H (1993) Endothelium-mediated coronary blood flow modulation in humans. Effects of age, atherosclerosis, hypercholesterolemia, and hypertension. J Clin Invest 92:652–662

    Article  CAS  Google Scholar 

  26. Caliskan M, Erdogan D, Gullu H, Topcu S, Ciftci O, Yildirir A, Muderrisoglu H (2007) Effects of atorvastatin on coronary flow reserve in patients with slow coronary flow. Clin Cardiol 30:475–479

    Article  Google Scholar 

  27. Kinlay S, Plutzky J (1999) Effect of lipid-lowering therapy on vasomotion and endothelial function. Curr Cardiol Rep 1:238–243

    Article  CAS  Google Scholar 

  28. Shepherd J, Cobbe SM, Ford I, Isles CG, Lorimer AR, MacFarlane PW, McKillop JH, Packard CJ (1995) Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of scotland coronary prevention study group. N Engl J Med 333:1301–1307

    Article  CAS  Google Scholar 

  29. No authors listed (1994) Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the scandinavian simvastatin survival study (4s). Lancet 344(8934):1383–1389

    Google Scholar 

  30. Shimada T, Osakada K, Okabe K, Shima Y, Eguchi H, Habara S, Tada T, Taguchi Y, Ikuta A, Takamatsu M, Murai R, Miura K, Ohya M, Amano H, Kubo S, Tanaka H, Maruo T, Fuku Y, Katoh H, Goto T, Kadota K (2020) Impact of high-dose statin on cardiovascular outcomes in real-world patients with ST-elevation acute myocardial infarction. Heart Vessels. https://doi.org/10.1007/s00380-020-01696-9

    Article  PubMed  Google Scholar 

  31. Nakamura A, Sato K, Kanazawa M, Kondo M, Endo H, Takahashi T, Nozaki E (2019) Impact of decreased insulin resistance by ezetimibe on postprandial lipid profiles and endothelial functions in obese, non-diabetic-metabolic syndrome patients with coronary artery disease. Heart Vessels 34:916–925

    Article  Google Scholar 

  32. Flammer AJ, Anderson T, Celermajer DS, Creager MA, Deanfield J, Ganz P, Hamburg NM, Luscher TF, Shechter M, Taddei S, Vita JA, Lerman A (2012) The assessment of endothelial function: from research into clinical practice. Circulation 126:753–767

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Kiyotaka Kugiyama.

Ethics declarations

Conflict of interest

All authors certify that they have NO affiliations with or involvement in any organization or entity with any financial interest, or non-financial interest in this manuscript.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Horikoshi, T., Nakamura, T., Yoshizaki, T. et al. Impact of persistent endothelial dysfunction in an infarct-related coronary artery on future major adverse cardiovascular event occurrence in STEMI survivors. Heart Vessels 36, 472–482 (2021). https://doi.org/10.1007/s00380-020-01723-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00380-020-01723-9

Keywords

Navigation